How Open Data Standards Enable Artificial Intelligence in Pharma

DATE

May 6, 2021

TIME

8:00 a.m. PDT, 11:00 a.m. EDT, 16:00 BST, 17:00 CEST

Duration: 60 minutes

Overview

Artificial intelligence (AI) has long been touted as a game changer for pharma, so why are there so few examples of AI-driven drugs on the market?

In this webinar, we’ll explore the structural roadblocks that are impeding drug discovery programs, and discuss how FAIR data principles and open standards can accelerate speed to market and enable enterprise-wise digital transformation. In addition, we will consider pragmatic steps your lab can take today to harmonize your data inputs and automate data capture.

Brought to you by:

Speakers

Dr. Haydn Boehm
Head of Commercial Marketing,
Connected Lab, MilliporeSigma

Kelly McSweeney
Contributing Editor,
C&EN Media Group

Registration

Forwarded this event? Clear the form

Email Address*

Salutation

First Name*

Last Name*

Company*

Job Title*

Country*

Business Phone*

Is all your lab data readily accessible in a standardized format?*

Are your data archives accessible for secondary use applications, such as AI, ML or predictive analytics?*

What is your timeline for evaluating lab data solutions?*

I would like to receive more information on products and services from the American Chemical Society

*By submitting this form, you agree to receive more information on related products and services from the American Chemical Society (ACS Publications) via email, in accordance with the ACS Privacy Policy.

View On Demand Webinars